A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-07
DOI
10.3389/fneur.2020.00614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Combinations for Alzheimer’s Disease: Current And Future Pharmacotherapy Options
- (2019) Jeffrey L. Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Neuropathological correlates and genetic architecture of microglial activation in elderly human brain
- (2019) Daniel Felsky et al. Nature Communications
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
- (2019) Brian W. Kunkle et al. NATURE GENETICS
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
- (2019) Peter T Nelson et al. BRAIN
- The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis
- (2019) Martin Tolar et al. Alzheimers & Dementia
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment
- (2018) Pei-Yuan Lyu et al. CHINESE MEDICAL JOURNAL
- Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
- (2018) Yu Gao et al. Current Alzheimer Research
- Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome
- (2018) Jing Zhao et al. JOURNAL OF NEUROTRAUMA
- Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
- (2018) Melissa C. Wren et al. Acta Neuropathologica Communications
- Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
- (2018) John A. Hey et al. CNS DRUGS
- Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
- (2018) Victoria Larsson et al. PLoS One
- The antimicrobial protection hypothesis of Alzheimer's disease
- (2018) Robert D. Moir et al. Alzheimers & Dementia
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
- (2018) Paola Bossù et al. Frontiers in Aging Neuroscience
- Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study
- (2017) Javier Olazarán et al. INTERNATIONAL PSYCHOGERIATRICS
- Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson’s disease: a reappraisal
- (2017) Raffaele Nardone et al. JOURNAL OF NEURAL TRANSMISSION
- Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction
- (2017) Viviana Versace et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Intensive LDL-cholesterol lowering therapy and neurocognitive function
- (2017) Maciej Banach et al. PHARMACOLOGY & THERAPEUTICS
- Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
- (2017) Carl F. Eliassen et al. Brain and Behavior
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment
- (2016) Gianfranco Spalletta et al. JOURNAL OF ALZHEIMERS DISEASE
- Epidemiologia da Demência e da Doença de Alzheimer em Portugal: Estimativas da Prevalência e dos Encargos Financeiros com a Medicação
- (2015) Isabel Santana et al. Acta Medica Portuguesa
- Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer’s disease
- (2015) Vincenzo De Luca et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson’s disease
- (2015) Kyung Duck Lee et al. JOURNAL OF NEURAL TRANSMISSION
- Homotaurine in Parkinson’s disease
- (2015) Lucia Ricciardi et al. NEUROLOGICAL SCIENCES
- Clinical Features of Alzheimer Disease With and Without Lewy Bodies
- (2015) Eun Joo Chung et al. JAMA Neurology
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
- (2014) Ada Tata et al. CNS & Neurological Disorders-Drug Targets
- Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
- (2014) Gennaro Pagano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals
- (2014) Alessandro Martorana et al. Frontiers in Aging Neuroscience
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease
- (2012) L. Rochester et al. BRAIN
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: The Alzhemedtm (Tramiprosate) experience
- (2009) D. Saumier et al. Journal of Nutrition Health & Aging
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
- (2009) Joseph L. Price et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation